Vineeth Sukrithan

666 total citations
35 papers, 324 citations indexed

About

Vineeth Sukrithan is a scholar working on Oncology, Epidemiology and Cancer Research. According to data from OpenAlex, Vineeth Sukrithan has authored 35 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Epidemiology and 8 papers in Cancer Research. Recurrent topics in Vineeth Sukrithan's work include Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Research Studies (9 papers) and Neuroblastoma Research and Treatments (6 papers). Vineeth Sukrithan is often cited by papers focused on Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Research Studies (9 papers) and Neuroblastoma Research and Treatments (6 papers). Vineeth Sukrithan collaborates with scholars based in United States, Germany and Australia. Vineeth Sukrithan's co-authors include Karen A. Robinson, Victor D. Dinglas, Pedro A. Mendez-Tellez, Dale M. Needham, Cheryl Dennison Himmelfarb, Bhavana Konda, Manisha H. Shah, Balázs Halmos, Rasim Gucalp and Richard J. Gralla and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Vineeth Sukrithan

30 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vineeth Sukrithan United States 8 125 72 53 51 44 35 324
Conrad Lee Hong Kong 10 115 0.9× 55 0.8× 37 0.7× 16 0.3× 26 0.6× 27 334
Xiuni Gan China 10 34 0.3× 16 0.2× 43 0.8× 65 1.3× 27 0.6× 37 268
Gilberto Morgan‐Villela Mexico 12 111 0.9× 22 0.3× 68 1.3× 15 0.3× 38 0.9× 28 311
Susan Storey United States 14 185 1.5× 196 2.7× 68 1.3× 10 0.2× 52 1.2× 40 479
Emma L. Jones United Kingdom 10 108 0.9× 25 0.3× 53 1.0× 13 0.3× 50 1.1× 11 497
Ramy Sedhom United States 14 289 2.3× 148 2.1× 64 1.2× 10 0.2× 229 5.2× 82 696
Susan McCammon United States 13 73 0.6× 61 0.8× 53 1.0× 5 0.1× 182 4.1× 38 455
Elżbieta Cipora Poland 12 144 1.2× 34 0.5× 22 0.4× 6 0.1× 42 1.0× 55 362
John D. Cowan United States 12 201 1.6× 61 0.8× 71 1.3× 60 1.2× 217 4.9× 20 544
Tzu-Chi Lee Taiwan 12 83 0.7× 42 0.6× 127 2.4× 7 0.1× 31 0.7× 13 412

Countries citing papers authored by Vineeth Sukrithan

Since Specialization
Citations

This map shows the geographic impact of Vineeth Sukrithan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vineeth Sukrithan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vineeth Sukrithan more than expected).

Fields of papers citing papers by Vineeth Sukrithan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vineeth Sukrithan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vineeth Sukrithan. The network helps show where Vineeth Sukrithan may publish in the future.

Co-authorship network of co-authors of Vineeth Sukrithan

This figure shows the co-authorship network connecting the top 25 collaborators of Vineeth Sukrithan. A scholar is included among the top collaborators of Vineeth Sukrithan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vineeth Sukrithan. Vineeth Sukrithan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sen, Triparna, Virginia Corbett, Sonam Puri, et al.. (2025). Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies. The Lancet Oncology. 26(1). e13–e33. 8 indexed citations
2.
Tsilimigras, Diamantis I., Pamela Lu, Timothy M. Pawlik, et al.. (2025). Appendiceal Neuroendocrine Tumors: Prognostic Role of Mesoappendiceal Invasion and Implications for Recommending Right Hemicolectomy versus Simple Appendectomy. Annals of Surgical Oncology. 32(10). 7627–7633.
3.
Sukrithan, Vineeth, Kimberly Perez, Neeta Pandit‐Taskar, & Camilo Jiménez. (2024). Management of metastatic pheochromocytomas and paragangliomas: when and what. Current Problems in Cancer. 51. 101116–101116. 4 indexed citations
4.
Tarhini, Ahmad A., Dale J. Hedges, Aik Choon Tan, et al.. (2024). Differences in Co-Expression of T Cell Co-Inhibitory and Co-Stimulatory Molecules with PD-1 Across Different Human Cancers. PubMed. 9(2). 1 indexed citations
5.
Sukrithan, Vineeth, Cassandra Grenade, Claire F. Verschraegen, et al.. (2024). Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience. PLoS ONE. 19(5). e0298824–e0298824. 3 indexed citations
6.
Ruff, Samantha M., et al.. (2024). Trends in the Use of Observation for Small Nonfunctional Pancreatic Neuroendocrine Tumors. JAMA Surgery. 159(11). 1318–1318. 3 indexed citations
7.
Ruff, Samantha M., Menglin Xu, Aslam Ejaz, et al.. (2024). Trans-arterial embolization versus chemoembolization for neuroendocrine liver metastases: a propensity matched analysis. HPB. 26(12). 1505–1514. 2 indexed citations
8.
Sukrithan, Vineeth, Briant Fruth, Rui Qin, et al.. (2023). A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors. Endocrine Related Cancer. 30(11). 4 indexed citations
9.
Sukrithan, Vineeth, Jennifer A. Sipos, Ye Zhou, et al.. (2023). Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib. SHILAP Revista de lepidopterología. 2023. 1–4. 2 indexed citations
10.
Wang, Xuefeng, Vineeth Sukrithan, Aakrosh Ratan, et al.. (2023). Incorporating long non-coding RNA (lncRNA) into genome-wide biomarker screening for prognostic gene signatures of immunotherapy outcomes.. Journal of Clinical Oncology. 41(16_suppl). 2617–2617. 2 indexed citations
11.
Sukrithan, Vineeth, et al.. (2023). Kinase inhibitors in thyroid cancers. SHILAP Revista de lepidopterología. 3(1). e220062–e220062. 6 indexed citations
12.
Makary, Mina S., Luis E. Regalado, Jonathan Alexánder, et al.. (2023). Clinical Outcomes of DEB-TACE in Hepatic Metastatic Neuroendocrine Tumors: A 5-Year Single-Institutional Experience. Academic Radiology. 30. S117–S123. 7 indexed citations
13.
Shah, Manisha H., et al.. (2022). An Evaluation of Clinical Efficacy of Immune Checkpoint Inhibitors for Patients with Anaplastic Thyroid Carcinoma. Thyroid. 32(8). 926–936. 26 indexed citations
14.
Tarhini, Ahmad A., Dale J. Hedges, Aik Choon Tan, et al.. (2022). 1147 Differences in co-expression of T cell co-inhibitory and co-stimulatory molecules with PD1 across different human cancers. Regular and Young Investigator Award Abstracts. A1190–A1190.
15.
Nabhan, Fadi, Rulong Shen, Amit Agrawal, et al.. (2021). Pembrolizumab in a Patient with Treatment‐Naïve Unresectable BRAF‐Mutation Negative Anaplastic Thyroid Cancer. SHILAP Revista de lepidopterología. 2021(1). 5521649–5521649. 5 indexed citations
16.
Zhao, Hongling, et al.. (2020). Targeted Inhibition of the E3 Ligase SCFSkp2/Cks1 Has Antitumor Activity in RB1 -Deficient Human and Mouse Small-Cell Lung Cancer. Cancer Research. 80(11). 2355–2367. 28 indexed citations
17.
Sukrithan, Vineeth, et al.. (2018). Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma. Clinical Lung Cancer. 20(3). e242–e246. 25 indexed citations
18.
Robinson, Karen A., Victor D. Dinglas, Pedro A. Mendez-Tellez, et al.. (2016). A systematic review finds limited data on measurement properties of instruments measuring outcomes in adult intensive care unit survivors. Journal of Clinical Epidemiology. 82. 37–46. 33 indexed citations
19.
20.
Robinson, Karen A., Victor D. Dinglas, Vineeth Sukrithan, et al.. (2015). Updated systematic review identifies substantial number of retention strategies: using more strategies retains more study participants. Journal of Clinical Epidemiology. 68(12). 1481–1487. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Conrad Lee Breakdown of academic impact, for papers by Xiuni Gan Breakdown of academic impact, for papers by Gilberto Morgan‐Villela Breakdown of academic impact, for papers by Susan Storey Breakdown of academic impact, for papers by Emma L. Jones Breakdown of academic impact, for papers by Ramy Sedhom Breakdown of academic impact, for papers by Susan McCammon Breakdown of academic impact, for papers by Elżbieta Cipora Breakdown of academic impact, for papers by John D. Cowan Breakdown of academic impact, for papers by Tzu-Chi Lee
Rankless by CCL
2026